Trial Profile
A Single-centre, Randomised, Double-blind, Cross-over Trial Comparing the Within-subject Variability of the Pharmacokinetic Profiles of Insulin Detemir and Insulin Glargine in Children and Adolescents With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 28 Dec 2011 New trial record